10.3760/cma.j.issn.2096-5540.2018.02.006
Biologic treatments for psoriasis in China: current status and potential tuberculosis and hepatitis B virus risks
Introduction Psoriasis is a chronic,recurrent skin disease featured by scaly papules or plaques.Although the vast majority of patients have mild psoriasis,approxi-mately 20%-30% of patients have moderate or severe psoriasis,which is defined as body surface area (BSA) > 10,psoriasis area and severity index (PASI) > 10,and dermatology life quality index (DLQI) > 10.These patients have severe symptoms and worse quality of life,warranting consideration of systemic therapy”1”.Biologic treatments directly target specific steps in the pathogenesis of psoriasis,providing a revolution for treatment.
the Key Program of the National Natural Science Foundation of China81430073;General Program of the National Science Foundation of China81371738
2018-08-13(万方平台首次上网日期,不代表论文的发表时间)
共8页
99-106